Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-26T18:03:58.295Z Has data issue: false hasContentIssue false
  • English
  • Français

Central anticholinergic syndrome in the intensive care unit

Published online by Cambridge University Press:  23 December 2004

B. L. De Keulenaer ,
S. Philpot ,
M. Wilkinson ,
D. P. Stephens  and
A. DeBacker
B. L. De Keulenaer
Affiliation:
Royal Darwin Hospital, Northern Territory, Australia
S. Philpot
Affiliation:
Royal Darwin Hospital, Northern Territory, Australia
M. Wilkinson
Affiliation:
Royal Darwin Hospital, Northern Territory, Australia
D. P. Stephens
Affiliation:
Royal Darwin Hospital, Northern Territory, Australia
A. DeBacker
Affiliation:
Department of Radiology, Campus Stuivenberg, Antwerp, Belgium
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
European Journal of Anaesthesiology , Volume 21 , Issue 6 , June 2004 , pp. 499 - 501
Copyright
2004 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Link J, Papadopoulos G, Dopjans D, Guggenmoos-Holzmann I, Eyrich K. Distinct central anticholinergic syndrome following general anaesthesia. Eur J Anaesthesiol 1997; 14: 15–23.Google Scholar
Schneck H, Rupreht J. Central anticholinergic syndrome (CAS) in anesthesia and intensive care. Acta Anaesthy Belgica 1989; 40: 219–228.Google Scholar
Longo VG, Baldessarini R. Behavioral and electroencephalographic effects of atropine and related compounds. Pharmacol Rev 1966; 18: 965–996.Google Scholar
Granacher R, Baldessarini R. Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs. Arch Gen Psychiatry 1975;32: 375–380.Google Scholar
Rupreht J. The central muscarinic transmission during anaesthesia and recovery – the central anticholinergic syndrome. Anaesthesiol Reanimat 1991; 16: 250–258.Google Scholar
Schneck HJ. Besonderheiten der zentral wirkenden Medikation in Anasthesie und Intensivmedizin unter spezieleer berucksichitgung anticholierger phanomene. Munich, Germany: Habilitationschrift der Technishen Universitat Munchen, 1988.
Katsanoulas K, Papaioannou A, Fraidakis O, Michaloudis D. Undiagnosed central anticholinergic syndrome may lead to dangerous complications. Eur J Anaesthesiol 1999; 16: 803–809.Google Scholar